Experimental pharmacotherapeutics for schizophrenia and addiction.
Jahnke
Ulrike
U
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. ulrike.jahnke@thomson.com
D003605:D-Amino-Acid Oxidase / Q000037:antagonists & inhibitors; D015507:Drugs, Investigational / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D015394:Molecular Structure; D009570:Nitriles / Q000737:chemistry / Q000627:therapeutic use; D011799:Quinazolines / Q000737:chemistry / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000188:drug therapy*; D044005:Tetrahydroisoquinolines / Q000737:chemistry / Q000627:therapeutic use
C451939:4-((Diphenylmethyl)amino)-2-phenylquinazoline; D015507:Drugs, Investigational; D009570:Nitriles; D011799:Quinazolines; C409982:SB 277011; D044005:Tetrahydroisoquinolines; D003605:D-Amino-Acid Oxidase